MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Net insider -$962K over 180 days (0 open-market buys, 2 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 3.4%/yr (revenue basis).
Base free cash flow $661M (avg FY2023–FY2025; latest year $712M) · equity value $13.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $205 avg across 3 analysts.
Buy-rated share 82% → 82% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $2.32 | $2.42 | +4.3% |
| Jul 2026 | $2.47 | $2.89 | +17.0% |
| Apr 2026 | $2.43 | $2.47 | +1.6% |
| Feb 2026 | $2.40 | $2.45 | +2.1% |
| Oct 2025 | $2.33 | $2.37 | +1.7% |
| Jul 2025 | $2.39 | $2.42 | +1.3% |
| Apr 2025 | $2.32 | $2.30 | -0.9% |
| Jan 2025 | $2.39 | $2.38 | -0.4% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $8.4B— | $9.0B+7.5% | $8.4B-7.5% | $8.8B+4.7% | $8.9B+1.1% |
| EPS (dil.) | $8.83— | $9.21+4.3% | $6.20-32.7% | $8.73+40.8% | $8.78+0.6% |
| Free Cash Flow | $775M— | $663M-14.5% | $541M-18.4% | $730M+35.0% | $712M-2.4% |
| Gross Margin | 27.5% | 26.5%-0.9pp | 27.2%+0.7pp | 28.9%+1.7pp | 28.8%-0.1pp |
| Operating Margin | 12.4% | 11.9%-0.5pp | 11.4%-0.4pp | 12.9%+1.5pp | 12.5%-0.4pp |
| Net Margin | 8.8% | 8.4%-0.4pp | 6.0%-2.4pp | 8.1%+2.0pp | 7.8%-0.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
The QScore of 57 for Avery Dennison Corporation indicates a neutral outlook, with the short-term score slightly outpacing the long-term score. The stock scores high on risk, with a low beta and moderate volatility, and exhibits strong momentum, driven by a 5% return over the past three months. However, it trades at a premium, with a P/E of 19.6, and scores lower on growth, due to modest revenue and EPS growth. The company's profitability is a mixed bag, with a strong ROE near 31%, but lower operating margin.